John W. Boslego

7.5k citations

51 papers · 3.4k indexed · 1 hit paper · h-index 26

Epidemiology top 1%
Microbiology top 0.2%
Surgery top 5%
Infectious Diseases top 2%
Immunology top 5%

Co-authors: Wendell D. Zollinger Suzanne M. Garland Frank J. Taddeo Grace Tang Micki Nelson Janine T. Bryan Daron G. Ferris Sepp Leodolter
Topics: Bacterial Infections and Vaccines (21 papers)Reproductive tract infections research (13 papers)Influenza Virus Research Studies (11 papers)
Cited by: Microbiology Epidemiology Infectious Diseases
Journals: New England Journal of Medicine The Lancet Journal of Clinical Investigation
Partner nations: United States Canada Switzerland

In The Last Decade

John W. Boslego

51 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases

2007 1.4k citations John W. Boslego et al. profile →

Peers

Countries citing papers authored by John W. Boslego

Since Specialization

Citations

This map shows the geographic impact of John W. Boslego's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John W. Boslego with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John W. Boslego more than expected).

Fields of papers citing papers by John W. Boslego

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John W. Boslego. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John W. Boslego. The network helps show where John W. Boslego may publish in the future.

Co-authorship network of co-authors of John W. Boslego

This figure shows the co-authorship network connecting the top 25 collaborators of John W. Boslego. A scholar is included among the top collaborators of John W. Boslego based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John W. Boslego. John W. Boslego is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	PATH Influenza Vaccine Project: accelerating the development of new influenza vaccines for low-resource countries 2012 ·Expert Review of Vaccines ·Kathleen M. Neuzil,Vadim Tsvetnitsky,(unknown),Rick A. Bright,John W. Boslego,(unknown)	7
2	Safety and immunogenicity of three different formulations of a liquid hexavalent diphtheria–tetanus–acellular pertussis–inactivated poliovirus–Haemophilus influenzae b conjugate–hepatitis B vaccine at 2, 4, 6 and 12–14 months of age 2010 ·Vaccine ·Francisco Díaz‐Mitoma,Scott A. Halperin,Bruce Tapiéro,Agnès Hoffenbach,(unknown),David Radley,Susan Bradshaw,Jason Martin,John W. Boslego,Teresa M. Hesley,Prakash Bhuyan,Jeffrey L. Silber	8
3	Safety and Immunogenicity of Two Formulations of a Hexavalent Diphtheria-Tetanus-Acellular Pertussis-Inactivated Poliovirus-Haemophilus influenzaeb Conjugate-Hepatitis B Vaccine in 15 to 18 Month-Old Children 2005 ·Human Vaccines ·Scott A. Halperin,Joanne M. Langley,Teresa M. Hesley,(unknown),David Radley,Bruce R. Smith,Agnès Hoffenbach,John W. Boslego,Jeffrey L. Silber	11
4	Post-licensure comparative study of unusual high-pitched crying and prolonged crying following COMVAX™ and placebo versus PedvaxHIB™ and RECOMBIVAX HB™ in healthy infants 2002 ·Vaccine ·Karen M. Kaplan,(unknown),Hassan Lakkis,(unknown),Fernando Guerra,(unknown),Harry Keyserling,Elise Felicione,Teresa M. Hesley,John W. Boslego	2
5	Large scale safety study of a liquid hexavalent vaccine (D-T-acP–IPV–PRP∼T–HBs) administered at 2, 4, 6 and 12–14 months of age 2001 ·Vaccine ·Johannes G. Liese,S Stojanov,(unknown),Pascal Minini,(unknown),(unknown),F. Schödel,John W. Boslego,A Hoffenbach,(unknown),B. H. Belohradsky	16
6	The effectiveness of Haemophilus influenzae type b conjugate vaccines in a high risk population measured using immunization register data 2001 ·Epidemiology and Infection ·Peter Markey,Vicki Krause,John W. Boslego,Paul Coplan,(unknown),(unknown)	18
7	Inflammatory Cytokines Produced in Response to Experimental Human Gonorrhea 1995 ·The Journal of Infectious Diseases ·Kyle H. Ramsey,H. Schneider,Alan S. Cross,John W. Boslego,David L. Hoover,(unknown),Robert A. Kuschner,Carolyn Deal	102
8	Public Health Implications of Emerging Vaccine Technologies 1995 ·Pharmaceutical biotechnology ·Dale N. Lawrence,Karen L. Goldenthal,John W. Boslego,D K Chandler,John R. La Montagne	3
9	Safety, immunogenicity and limited efficacy study of a recombinant Plasmodium falciparum circumsporozoite vaccine in Thai soldiers 1994 ·Vaccine ·Arthur E. Brown,Pricha Singharaj,H. Kyle Webster,(unknown),Daniel M. Gordon,John W. Boslego,(unknown),(unknown),Chansuda Wongsrichanalai,W. Ripley Ballou,Barnyen Permpanich,Kevin C. Kain,M.R. Hollingdale,Janet Wittes,J U Que,Mitchell Gross,S J Cryz,Jerald Sadoff	37
10	Age-Specific Prevalence of Serum Antibodies to the Invasion Plasmid and Lipopolysaccharide Antigens of Shigella Species in Chilean and North American Populations 1992 ·The Journal of Infectious Diseases ·Lillian L. Van De Verg,D A Herrington,John W. Boslego,Anne Lindberg,Myron M. Levine	45
11	Treatment of Malaria Acquired in Southeast Asia 1992 ·Military Medicine ·G. Dennis Shanks,John W. Boslego	1
12	Human Immunization with Pgh 3-2 Gonococcal Pilus Results in Cross-Reactive Antibody to the Cyanogen Bromide Fragment-2 of Pilin 1991 ·The Journal of Infectious Diseases ·Steven C. Johnson,R. Chung,Carolyn Deal,John W. Boslego,Jerald Sadoff,(unknown),Charles C. Brinton,Edmund C. Tramont	21
13	Expression of paragloboside-like lipooligosaccharides may be a necessary component of gonococcal pathogenesis in men. 1991 ·The Journal of Experimental Medicine ·H. Schneider,J. McLeod Griffiss,John W. Boslego,P J Hitchcock,(unknown),M. A. Apicella	151
14	Expression of outer membrane protein II by gonococci in experimental gonorrhea. 1988 ·The Journal of Experimental Medicine ·J Swanson,O Barrera,(unknown),John W. Boslego	129
15	Gonococcal pilin variants in experimental gonorrhea. 1987 ·The Journal of Experimental Medicine ·J Swanson,Kenneth E. Robbins,O Barrera,Dan Corwin,John W. Boslego,Jennie Ciak,(unknown),Michael Koomey	164
16	Pathogenesis and Management of Gonorrhea 1987 ·Advances in experimental medicine and biology ·Edmund C. Tramont,John W. Boslego	1
17	Analyses of the immunoaccessibility of H8 antigen and the functionality of H8 specific monoclonal antibody 10 1987 ·Antonie van Leeuwenhoek ·P J Hitchcock,John W. Boslego,Keith A. Joiner,(unknown)	3
18	Gene conversion accounts for pilin structural changes and for reversible piliation ?phase? changes in gonococci 1987 ·Antonie van Leeuwenhoek ·J Swanson,Sven Bergström,John W. Boslego,Michael Koomey	11
19	Human bactericidal antibody response to meningococcal outer membrane protein vaccines 1987 ·Antonie van Leeuwenhoek ·Wendell D. Zollinger,John W. Boslego,(unknown),(unknown),Elizabeth Morán,B. L. Brandt	30
20	Antigenic Specificity of Antibodies in Vaginal Secretions during Infection with Neisseria gonorrhoeae 1980 ·The Journal of Infectious Diseases ·Edmund C. Tramont,Jennie Ciak,John W. Boslego,Daniel G. McChesney,Charles C. Brinton,Wendell D. Zollinger	28

About John W. Boslego

John W. Boslego is a scholar working on Microbiology, Endocrinology and Infectious Diseases, having authored 51 papers that have together received 3.4k indexed citations. Recurring topics across this work include Bacterial Infections and Vaccines (21 papers), Reproductive tract infections research (13 papers) and Influenza Virus Research Studies (11 papers). The work is most often cited by research in Microbiology (1.3k citations), Epidemiology (1.8k citations) and Infectious Diseases (618 citations). John W. Boslego has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include Wendell D. Zollinger, Suzanne M. Garland, Frank J. Taddeo, Grace Tang, Micki Nelson, Janine T. Bryan, Daron G. Ferris, Sepp Leodolter, Cosette M. Wheeler and Mark T. Esser. Their work appears in journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact